|
Volumn 10, Issue 5, 2000, Pages 283-285
|
Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma
a a a a a a |
Author keywords
Asthma; FEV1; Fluticasone propionate; sCD30; Serum
|
Indexed keywords
CD30 ANTIGEN;
FLUTICASONE PROPIONATE;
ADULT;
AGED;
ANTIGEN DETECTION;
ARTICLE;
ASTHMA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG MECHANISM;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
IMMUNOMODULATION;
INFLAMMATION;
MALE;
PROTEIN SECRETION;
STEROID THERAPY;
TH2 CELL;
ADOLESCENT;
ADULT;
ANDROSTADIENES;
ANTI-ASTHMATIC AGENTS;
ANTIGENS, CD30;
ASTHMA;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
TH2 CELLS;
|
EID: 0033694532
PISSN: 10189068
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (16)
|